Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Deferasirox price, strengths & recalls

Pharmacies pay $33.58 for 30 tablets of Deferasirox 360 mg tablet this week, and from $33.58 to $175.57 across its 2 priced strengths and forms. 13 manufacturers make it. 1 recall is ongoing. Its official label last changed on December 4, 2024.

1 open recallGeneric
Pharmacies pay$33.58for 30 tablets of 360 mg tablet-10.3% in 4 weeks
Fair cash price
$49.12
Strengths
2
Makers
13
Updated
Nov 11

Deferasirox price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
180 mg tabletNot priced this week
360 mg tablet$1.12$33.58 / 30 tablets-10.3%-11.7%
500 mg tablet for oral suspension$5.85$175.57 / 30 tablets

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
1 ongoing recall1 recall on record, latest Nov 15, 2023

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for deferasirox? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedDecember 4, 2024
Version5 of 4
EffectiveSep 30, 2024
Read the label

These highlights do not include all the information needed to use DEFERASIROX TABLETS safely and effectively. See full prescribing information for DEFERASIROX TABLETS. DEFERASIROX tablets, for oral use Initial U.S. Approval: 2005

This drug has a boxed warning

WARNING: RENAL FAILURE, HEPATIC FAILURE, AND GASRTOINTESTINAL HEMORRHAGE

Renal Failure

Deferasirox can cause acute renal failure and death, particularly in patients with comorbidities and those who are in the advanced stages of their hematologic disorders.

Evaluate baseline renal function prior to starting or increasing deferasirox dosing in all patients. Deferasirox is contraindicated in adult and pediatric patients with eGFR less than 40 mL/min/1.73 m2. Measure serum creatinine in duplicate prior to initiation of therapy. Monitor renal function at least monthly. For patients with baseline renal impairment or increased risk of acute renal failure, monitor renal function weekly for the first month, then at least monthly. Reduce the starting dose in patients with preexisting renal disease. During therapy, increase the frequency of monitoring and modify the dose for patients with an increased risk of renal impairment, including use of concomitant nephrotoxic drugs, and pediatric patients with volume depletion or overchelation [see Dosage and Administration (2.1, 2.4, 2.5), Warnings and Precautions (5.1), Adverse Reactions (6.1, 6.2)].

Hepatic Failure

Deferasirox can cause hepatic injury including hepatic failure and death.

Measure serum transaminases and bilirubin in all patients prior to initiating treatment, every 2 weeks during the first month, and at least monthly thereafter.

Avoid use of deferasirox in patients with severe (Child-Pugh C) hepatic impairment and reduce the dose in patients with moderate (Child-Pugh B) hepatic impairment [see Dosage and Administration (2.4), Warnings and Precautions (5.2)].

Gastrointestinal Hemorrhage

Deferasirox can cause gastrointestinal (GI) hemorrhages, which may be fatal, especially in elderly patients who have advanced hematologic malignancies and/or low platelet counts.

Monitor patients and discontinue deferasirox for suspected GI ulceration or hemorrhage [see Warnings and Precautions (5.3)].

WARNING: RENAL FAILURE, HEPATIC FAILURE, AND GASTROINTESTINAL HEMORRHAGE

See full prescribing information for complete boxed warning.

Deferasirox may cause serious and fatal:

acute kidney injury, including acute renal failure requiring dialysis and renal tubular toxicity including Fanconi syndrome (5.1)

hepatic toxicity, including failure (5.2)

gastrointestinal hemorrhage (5.3)

Deferasirox therapy requires close patient monitoring, including laboratory tests of renal and hepatic function. (5)

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Generic makers
13 approved generic applications on the market

Deferasirox questions

How much does deferasirox cost without insurance?

Pharmacies pay about $33.58 for 30 tablets of deferasirox 360 mg tablet ($1.12 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $49.12. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is deferasirox in shortage?

No shortage is reported for deferasirox right now. We check the national shortage list every day.

Has deferasirox been recalled?

1 recall on record, 1 ongoing. Recalls name specific lots - check yours.

When did the deferasirox label last change?

The official label was last updated on December 4, 2024 (version 5). See what changed.

Talk about deferasirox

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.